Skip to main content
Premium Trial:

Request an Annual Quote

James Levine

Annai Systems has tapped James Levine to serve as its chief executive officer. He takes over from Michael Penley who will now serve as Annai's chief business officer. Prior to joining Annai, Levine served as CEO of Sapphire Energy and of Verenium Corporation. He's also previously worked as a managing director at Goldman Sachs.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.